AYTU · Company research
AYTU BioPharma, Inc. (AYTU): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? - The Globe and Mail | Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? The Globe and Mail | View source ↗ | The Globe and Mail | Oct 7, 2026 | neutral | 0 | 0.6 |
| Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? | Elite Pharmaceuticals (ELTP) and Aytu BioPharma (AYTU) are two pharmaceutical companies with CNS and ADHD market exposure, but with different strategies. ELTP focuses on generic pharmaceuticals with an expanding pipeline and strong financial position, while AYTU emphasizes branded medicines centered on its EXXUA growth catalyst. Despite both trading below sector valuations, ELTP is recommended as the better buy due to its broader commercial base, lower execution risk, and improving operating momentum, while AYTU presents a higher-risk turnaround story dependent on EXXUA's success. | View source ↗ | Zacks Investment Research | Oct 7, 2026 | bullish | 0.5 | 1 |
| Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? - Yahoo Finance | Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 7, 2026 | neutral | 0 | 0.6 |
| Aytu Biopharma Inc (AYTU-Q) Stock Price and News - The Globe and Mail | Aytu Biopharma Inc (AYTU-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma (NasdaqCM:AYTU) Stock Forecast & Analyst Predictions - Simply Wall Street | Aytu BioPharma (NasdaqCM:AYTU) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 30, 2026 | neutral | 0 | 0.6 |
| A depression drug generated $3.9 million in its first full quarter - Stock Titan | A depression drug generated $3.9 million in its first full quarter Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance | Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Sep 22, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma Reports $16.1 Million Q4 Revenue as EXXUA Reaches $3.9 Million - Quiver Quantitative | Aytu BioPharma Reports $16.1 Million Q4 Revenue as EXXUA Reaches $3.9 Million Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 22, 2026 | neutral | 0 | 0.6 |
| EXXUA prescriptions jump as Aytu BioPharma (AYTU) posts Q4 and full-year results - Stock Titan | EXXUA prescriptions jump as Aytu BioPharma (AYTU) posts Q4 and full-year results Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma Reports $16.1 Million Q4 Revenue as EXXUA Reaches $3.9 Million - Quiver Quantitative | Aytu BioPharma Reports $16.1 Million Q4 Revenue as EXXUA Reaches $3.9 Million Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 22, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma will share yearly results Sept. 22 - Stock Titan | Aytu BioPharma will share yearly results Sept. 22 Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| Aytu BioScience Inc (AYTU) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research | Aytu BioScience Inc (AYTU) Shareholding Pattern – Promoters, FIIs & DIIs Value Research | View source ↗ | Value Research | Aug 30, 2026 | neutral | 0 | 0.6 |
| Aytu Biopharma Inc (AYTU) Stock News Today - TradingKey | Aytu Biopharma Inc (AYTU) Stock News Today TradingKey | View source ↗ | TradingKey | Aug 8, 2026 | neutral | 0 | 0.6 |
| AYTU Forecast — Price Target — Prediction for 2027 - TradingView | AYTU Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Shift From Loss To Profit - Yahoo Finance | Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Shift From Loss To Profit Yahoo Finance | View source ↗ | Yahoo Finance | Feb 5, 2026 | neutral | 0 | 0.6 |
| Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock Catapults 28% Though Its Price And Business Still Lag The Industry - Simply Wall Street | Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock Catapults 28% Though Its Price And Business Still Lag The Industry Simply Wall Street | View source ↗ | Simply Wall Street | Dec 20, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 14, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.